Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$4 Mln
Revenue (TTM)
$5 Mln
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0
Industry P/E
28.32
EV/EBITDA
4.8
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
134,754,000
CFO
$-4.69 Mln
EBITDA
$-8.80 Mln
Net Profit
$-29.76 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Stemtech Corporation (STEK)
| -- | -- | -- | -- | -81.3 | -- | -- |
|
BSE Sensex*
| 4.0 | -1.2 | 9.7 | 5.7 | 16.6 | 19.4 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Stemtech Corporation (STEK)
|
0.0 | 4.5 | 5.1 | -5.2 | -13.6 | -- | -- | 0.0 |
| 18.9 | 4,870.2 | 459.4 | 206.8 | 25.6 | 68.3 | 24.3 | 13.3 | |
| 29.4 | 3,591.5 | 8.9 | -369.2 | -4,861.1 | -26.1 | -- | 2.7 | |
| 101.6 | 5,125.5 | 432.2 | -278.3 | -64.1 | -380.9 | -- | 94.1 | |
| 55.0 | 10,785.5 | 2,937.8 | 523.9 | 23.2 | 9.3 | 20.8 | 1.9 | |
| 40.1 | 7,811.7 | 127.4 | -668.0 | -432.9 | -- | -- | 123.7 | |
| 71.9 | 7,518.6 | 685.5 | 132.9 | 15.6 | 20.1 | 61.1 | 10.9 | |
| 13.6 | 6,948.1 | 4,427.0 | 373.0 | -0.7 | 5.8 | 18.7 | 1.1 | |
| 83.7 | 4,149.4 | 1,137.8 | 214.6 | 29.2 | 12.3 | 19.6 | 2.3 | |
| 8.8 | 10,469.2 | 14,317.0 | -3,790.1 | -23.7 | -21.4 | -- | 0.7 |
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. Its products enhance and support the work of the body's stem cells... by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. The company offers its dietary supplements products under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and D-Fuze brand names; and skincare products under the Cellect One brand name. It serves through independent distributors. Stemtech Corporation is headquartered in Miramar, Florida. Read more
CEO & Director
Mr. Charles S. Arnold
CEO & Director
Mr. Charles S. Arnold
Headquarters
Naples, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Stemtech Corporation (STEK) stood at $ 13 Mln as on 30-Sep-24
The share price of Stemtech Corporation (STEK) is $0.03 (NASDAQ) as of 17-Jun-2025 11:46 EDT. Stemtech Corporation (STEK) has given a return of -81.26% in the last 3 years.
Stemtech Corporation (STEK) has a market capitalisation of $ 4 Mln as on 13-Jun-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Stemtech Corporation (STEK) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Stemtech Corporation (STEK) and enter the required number of quantities and click on buy to purchase the shares of Stemtech Corporation (STEK).
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. The company offers its dietary supplements products under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and D-Fuze brand names; and skincare products under the Cellect One brand name. It serves through independent distributors. Stemtech Corporation is headquartered in Miramar, Florida.
The CEO & director of Mr. Charles S. Arnold. is Stemtech Corporation (STEK), and CFO & Sr. VP is Mr. Charles S. Arnold.
There is no promoter pledging in Stemtech Corporation (STEK).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,096
|
|
|
1,054
|
|
|
755
|
|
|
741
|
|
|
709
|
|
|
532
|
|
|
522
|
|
|
421
|
|
|
386
|
| Stemtech Corporation (STEK) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
-13.57
|
|
Net Margin(%)
|
-102.67
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Stemtech Corporation (STEK) was $0 Mln.
$0.00
(
